HopeStage
Back to all studies
WithdrawnNCT00621634

Efficacy of Docosahexaenoic Acid on Tardive Dyskinesia

Placebo comparisonAges 30–75CanadaSchizophrenia
The study in practice

Understand this study

Who could participate?

Listed age limits: 30 years to 75 years.

Listed locations
Montreal and 1 more locationSee all locations and recruitment

Get this study by email

HopeStage may email me about this study.
Loading the security check...

What to know before participating

A point to clarify

This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?

Study clarity

Things to check before joining

Study start dateEstimated: February 2008
Recruitment status
Withdrawn
Enrollment listed in the registry
0
Sponsor
Université de Montréal
Sponsor type
University
Study type
Other
Intervention type
Dietary supplement
Study phase
Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
Locations
Canada
Age range
From 30 Years to 75 Years
Official registry ID
NCT00621634
Official title
Show the full official title

Randomized, Double-blind, Placebo-controlled Trial on the Efficacy of Omega-3 Supplementation With Docosahexaenoic Acid (DHA) on Tardive Dyskinesia

Recruitment & locations

Withdrawn

Montreal

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is Université de Montréal, a university.

Who can participate?

Listed age limits: 30 years to 75 years.

Is this study still recruiting?

The registry lists this study as withdrawn.

Want to explore more studies?

Explore studies